MedPath

Effects of Eszopiclone on Sleep-dependent Learning in Schizophrenia

Not Applicable
Completed
Conditions
Schizophrenia
Interventions
Drug: placebo
Registration Number
NCT00833547
Lead Sponsor
Massachusetts General Hospital
Brief Summary

This study will determine whether eszopiclone will normalize sleep patterns and restore sleep-dependent enhancement of motor skill learning in patients with schizophrenia. The investigators will compare subjects taking a placebo to those taking 3 mg of eszopiclone with regard to: sleep architecture and sleep latency as measured by actigraphy and polysomnography and sleep-dependent motor skill learning.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
25
Inclusion Criteria
  • Clinically stable outpatients with DSM-IV diagnoses of Schizophrenia
Exclusion Criteria
  • History of neurologic or psychiatric disease other than schizophrenia
  • Substance abuse or dependence within the past six months
  • Other chronic medical conditions that affect sleep
  • Pregnancy/breast feeding
  • Hepatic impairment
  • Treatment with metabolic inhibitors or inducers

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
placeboplaceboplacebo capsule that looks identical to eszopiclone capsule on two consecutive nights
Eszopicloneeszopiclone3mg of eszopiclone on two consecutive nights
Primary Outcome Measures
NameTimeMethod
Overnight Change on Finger Tapping TaskTrain on Day 3 and Test on Day 4 of study (experimental nights)

The finger tapping task involves pressing four numerically labeled keys on a standard computer keyboard with the fingers of the left hand, repeating a five element sequence (4-1-3-2-4) "as quickly and accurately as possible" for 30s. During both training and test sessions, participants alternated tapping and resting for 30s for a total of 12 tapping trials. The measure was the number of correct sequences per trial. Overnight change was the percent change in correct sequences from the last three training trials to the first three test trials the following morning.

Sleep Spindle Density During Stage 2 Sleep as Measured by Polysomnographyduring two nights in an inpatient Clinical Research Center

2 baseline nights (Days 1 \&2); 2 experimental nights (Days 3 \&4)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mass General Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath